Patents by Inventor Florence Wahl

Florence Wahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for identifying an antagonist of guanine nucleotide releasing factor 1
    Patent number: 8852878
    Abstract: The invention concerns the use of whole or part of the GRF1 protein, or of cells expressing whole or part of the GRF1 protein, in methods for detecting compounds for preventing and/or treating pathologies or disorders of the central nervous system involving neuronal death, such as apoptosis, or related to leptin metabolism. The pathologies of the central nervous system are in particular cerebral ischemia, Parkinson's disease or Alzheimer's disease.
    Type: Grant
    Filed: August 3, 2011
    Date of Patent: October 7, 2014
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Michel Itier, Marie-Christine Multon, Gwénaëlle Ret, Jean-Marie Stutzmann, Florence Wahl
  • USE OF GRF1 PROTEIN FOR SCREENING MOLECULES
    Publication number: 20120009604
    Abstract: The invention concerns the use of whole or part of the GRF1 protein, or of cells expressing whole or part of the GRF1 protein, in methods for detecting compounds for preventing and/or treating pathologies or disorders of the central nervous system involving neuronal death, such as apoptosis, or related to leptin metabolism. The pathologies of the central nervous system are in particular cerebral ischemia, Parkinson's disease or Alzheimer's disease.
    Type: Application
    Filed: August 3, 2011
    Publication date: January 12, 2012
    Applicant: AVENTIS PHARMA SA
    Inventors: Jean-Michel ITIER, Marie-Christine MULTON, Gwénaëlle RET, Jean-Marie STUTZMANN, Florence WAHL
  • Use of grf1 protein for screening molecules
    Publication number: 20050100972
    Abstract: The invention concerns the use of whole or part of the GRF1 protein, or of cells expressing whole or part of the GRF1 protein, in methods for detecting compounds for preventing and/or treating pathologies or disorders of the central nervous system involving neuronal death, such as apoptosis, or related to leptin metabolism. The pathologies of the central nervous system are in particular cerebral ischemia, Parkinson's disease or Alzheimer's disease.
    Type: Application
    Filed: August 7, 2001
    Publication date: May 12, 2005
    Inventors: Jean-Michel Itier, Marie-Christine Multon, Gwenaelle Ret, Jean-Marie Stutzmann, Florence Wahl
  • Novel therapeutic application of enoxaparin
    Publication number: 20040214796
    Abstract: The present invention relates to the use of enoxaparin for reducing cerebral lesion size in the treatment of cerebral ischemia.
    Type: Application
    Filed: May 19, 2004
    Publication date: October 28, 2004
    Applicant: AVENTIS PHARMA S.A.
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl
  • Oligosaccharides, their preparation and pharmaceutical compositions containing them
    Patent number: 6617316
    Abstract: The present invention relates to oligosaccharides of formula: to mixtures thereof, to diastereoisomers thereof, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in preventing or treating a disease associated with an inflammatory process involving the production of nitric oxide.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: September 9, 2003
    Assignee: Aventis Pharma
    Inventors: Pierre Mourier, Elisabeth Perrin, Jean-marie Stutzmann, Christian Viskov, Florence Wahl
  • Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
    Patent number: 6579858
    Abstract: Cerebral edema is prevented and treated by administering an effective amount of a low molecular weight heparin.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: June 17, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Véronique Mary, Jérémy Pratt, Jean-Marie Stutzman, André Uzan, Florence Wahl
  • Use of low-molecular-weight heparins for the prevention and treatment of trauma of the central nervous system
    Patent number: 6380173
    Abstract: Trauma of the central nervous system is prevented and treated by administering an effective amount of a low molecular weight heparin.
    Type: Grant
    Filed: November 24, 1999
    Date of Patent: April 30, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Marie Stutzmann, André Uzan, Florence Wahl
  • Novel therapeutic application of enoxaparin
    Publication number: 20010041686
    Abstract: The present invention relates to the use of enoxaparin for the treatment of cerebral ischemia.
    Type: Application
    Filed: January 2, 2001
    Publication date: November 15, 2001
    Inventors: Veronique Mary, Jean-Marie Stutzmann, Andre Uzan, Florence Wahl